OTCMKTS:VTXPF - Victrex Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $36.32
  • Forecasted Upside: 71.32 %
  • Number of Analysts: 5
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$21.20
+0.30 (1.20%)

This chart shows the closing price for VTXPF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Victrex Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VTXPF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VTXPF

Analyst Price Target is $36.32
▲ +71.32% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Victrex in the last 3 months. The average price target is $36.32, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 71.32% upside from the last price of $21.20.

This chart shows the closing price for VTXPF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 5 contributing investment analysts is to hold stock in Victrex. This rating has held steady since September 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings
12/1/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 1 sell ratings
3/1/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
5/30/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 1 sell ratings
8/28/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 1 sell ratings
11/26/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 1 sell ratings
2/24/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
4/25/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
5/25/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/8/2022UBS GroupLower Price TargetGBX 2,150 ➝ GBX 1,750
12/8/2021Credit Suisse GroupLower Price TargetOutperform ➝ OutperformGBX 2,900 ➝ GBX 2,800
12/8/2021UBS GroupLower Price TargetSell ➝ SellGBX 2,170 ➝ GBX 2,150
10/27/2021BarclaysReiterated RatingEqual Weight
10/13/2021UBS GroupReiterated RatingSell
7/15/2021Morgan StanleyReiterated RatingEqual Weight
7/14/2021Berenberg BankUpgradeHold
7/12/2021UBS GroupSet Price TargetSell$36.32
6/30/2021Credit Suisse GroupReiterated RatingOutperform
6/29/2021Morgan StanleyUpgradeUnderweight ➝ Equal Weight
5/12/2021Jefferies Financial GroupReiterated RatingBuy
5/12/2021UBS GroupReiterated RatingSell
5/11/2021Credit Suisse GroupReiterated RatingOutperform
5/11/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
4/14/2021UBS GroupReiterated RatingSell
4/1/2021Stifel NicolausUpgradeHold ➝ Buy
3/30/2021CitigroupUpgradeSell ➝ Neutral
3/30/2021Exane BNP ParibasUpgradeNeutral ➝ Outperform
2/24/2021BarclaysReiterated RatingEqual Weight
2/5/2021Morgan StanleyReiterated RatingUnderweight
12/15/2020Berenberg BankReiterated RatingHold
12/14/2020Peel HuntUpgradeHold ➝ Buy
12/10/2020UBS GroupReiterated RatingSell
12/10/2020BarclaysUpgradeUnderweight ➝ Equal Weight
12/1/2020BarclaysReiterated RatingUnderweight
10/7/2020CSFBReiterated RatingOutperform
10/7/2020Credit Suisse GroupReiterated RatingOutperform
8/24/2020BarclaysReiterated RatingUnderweight
7/22/2020Morgan StanleyReiterated RatingUnderweight
7/8/2020UBS GroupReiterated RatingSell
6/24/2020BarclaysReiterated RatingUnderweight
6/1/2020Liberum CapitalDowngradeBuy ➝ Hold
5/19/2020Jefferies Financial GroupInitiated CoverageBuy
5/7/2020BarclaysReiterated RatingUnderweight
3/30/2020Morgan StanleyReiterated RatingUnderweight
3/24/2020JPMorgan Chase & Co.Reiterated RatingNeutral
3/23/2020Morgan StanleyReiterated RatingUnderweight
(Data available from 5/25/2017 forward)

News Sentiment Rating

0.07 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/27/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/26/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/26/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/25/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/24/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/26/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/25/2022
  • 0 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/25/2022

Current Sentiment

  • 0 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Victrex logo
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company operates through two segments, Industrial and Medical. It develops PEEK and PAEK polymer solutions, and semi-finished and finished parts. The company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities. It serves automotive, aerospace, energy and industrial, manufacturing and engineering, electronics, and medical markets. Victrex plc was founded in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.
Read More

Today's Range

Now: $21.20
Low: $21.20
High: $21.20

50 Day Range

MA: $23.05
Low: $20.69
High: $25.64

52 Week Range

Now: $21.20
Low: $20.69
High: $36.50

Volume

N/A

Average Volume

714 shs

Market Capitalization

$1.83 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.14

Frequently Asked Questions

What sell-side analysts currently cover shares of Victrex?

The following sell-side analysts have issued reports on Victrex in the last twelve months: Barclays PLC, Berenberg Bank, Credit Suisse Group AG, Morgan Stanley, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for VTXPF.

What is the current price target for Victrex?

0 Wall Street analysts have set twelve-month price targets for Victrex in the last year. Their average twelve-month price target is $36.32, suggesting a possible upside of 71.3%.
View the latest price targets for VTXPF.

What is the current consensus analyst rating for Victrex?

Victrex currently has 1 sell rating, 3 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in VTXPF, but not buy more shares or sell existing shares.
View the latest ratings for VTXPF.

How do I contact Victrex's investor relations team?

Victrex's physical mailing address is Hillhouse International Thornton Cleveleys, Lancashire X0, FY5 4QD. The company's listed phone number is 441253897700 and its investor relations email address is [email protected] The official website for Victrex is www.victrexplc.com. Learn More about contacing Victrex investor relations.